Drug agreement

Omega signs ‘milestone’ Covid-19 test deal

Omega Diagnostics

Omega will supply more than 100 clinics

Scottish drug developer Omega has signed a partnership agreement with DAM Health to exclusively supply its COVID-19 antigen tests to more than 100 clinics throughout the UK and Europe.

Omega has already received an initial purchase order worth in excess of £750,000 from DAM Health which is currently using approximately 200,000 in-clinic COVID tests per month.

In a statement to the stock market, Omega said: “With COVID-19 cases surging again and PCR requirements being replaced with Antigen LFTs, this partnership, which is for an initial period of 12-months, sees two innovative and pioneering UK companies combining their expertise and knowledge as we learn to live with COVID-19.”

There is the possibility to broaden the partnership to include Omega’s antigen self-test LFT (once approved) and for DAM Health to sell Omega’s food detective product throughout its network.

Leave a Reply

Your email address will not be published. Required fields are marked as *

This site uses Akismet to reduce spam. Learn how your comment data is processed.